Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NVDA
6. AMAT
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c

February 5, 2026 4:11 PM EST

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $264.03 million versus the consensus estimate of $227.61 million.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.

... More